Sex-dependent association of phosphodiesterase 4D gene polymorphisms with ischemic stroke in Henan Han population

Chinese Medical Journal

Volumn 125, Issue 13, 2012, Pages 2255-2259

  He, Ying ^a   Bai, Jun yu ^a   Song, Bo ^b   Tan, Song ^b   Chang, Yin shu ^a   Li, Tao ^a   Shi, Cong cong ^a   Zhang, Hua ^a   Feng, Qing chuan ^a   Qi, Hua ^a   Song, Guo ying ^a   Zheng, Hong ^a   Xu, Yu ming ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Haplotypes; Phosphodiesterase 4D; Polymorphism; Stroke

Indexed keywords

ADULT; ALLELE; ARTICLE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPING TECHNIQUE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOSPHODIESTERASE 4D GENE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; BRAIN ISCHEMIA; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEX FACTORS; STROKE;

EID: 84863803747     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.13.003     Document Type: Article

References (26)

1. Li YF, Huang Y, Amsdell SL, Xiao L, O'Donnell JM, Zhang HT. Antidepressant-and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus. Neuropsychopharmacology 2009; 34: 2404-2419.
2. Humphries SE, Morgan L. Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol 2004; 3: 227-235.
3. Gretarsdottir S, Thorleifsson G, Reynisdottir ST, Manolescu A, Jonsdottir S, Jonsdottir T, et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 2003; 35: 131-138.
4. Wang HD, Wang YP, Qu Y, Qi RB, Lu DX, Li CJ, et al. The cAMP-mediated protein kinase transduction pathway is involved in the pyrogenic effect of CRH in rats. Chin Med J 2001; 114: 1064-1067.
5. Fidani L, Clarimon J, Goulas A, Hatzitolios AI, Evans W, Tsirogianni E, et al. Association of phosphodiesterase 4D gene G0 haplotype and ischemic stroke in a Greek population. Eur J Neurol 2007; 14: 745-749.
6. Rosand J, Bayley N, Rost N, de Bakker PI. Many hypotheses but no replication for the association between PDE4D and stroke. Nat Genet 2006; 38: 1091-1092.
7. Woo D, Kaushal R, Kissela B, Sekar P, Wolujewicz M, Pal P, et al. Association of phosphodiesterase 4D with ischemic stroke: a population-based case-control study. Stroke 2006; 37: 371-376.
8. Milton AG, Aykanat VM, Hamilton-Bruce MA, Nezic M, Jannes J, Koblar SA. Association of the phosphodiesterase 4D (PDE4D) gene and cardioembolic stroke in an Australian cohort. Int J Stroke 2011; 2: 1-7.
9. Connor EB. Sex differences in coronary heart disease: why are women so superior? Circulation 1997; 95: 252-264.
10. Tyrell KS, Lassila HC, Meilahn E, Bunker C, Matthews KA, Kuller LH. Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke 1998; 29: 1116-1121.
11. Zee RY, Brophy VH, Cheng S, Hegener HH, Erlich HA, Ridker PM. Polymorphisms of the phosphodiesterase 4D, cAMP-specific (PDE4D) gene and the risk of ischemic stroke: a prospective, nested case-control evaluation. Stroke 2006; 37: 2012-2017.
12. Barbazuk WB, Schnable PS. SNP discovery by transcriptome pyrosequencing. Methods Mol Biol 2011; 729: 225-246.
13. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
14. Cheng JQ, Liu JP, Li XX, Yu L, Peng J, Zhang RL, et al. Effect of polymorphisms of endothelial nitric oxide synthase on ischemic stroke: a case-control study in a Chinese population. Clin Chim Acta 2008; 392: 46-51.
15. Nakayama T, Asai S, Sato N, Soma M. Genotype and haplotype association study of the STRK1 region on 5q12 among Japanese: a case-control study. Stroke 2006; 37: 69-76.
16. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005; 15: 97-98.
17. Song Q, Cole JW, O'connell JR, Stine OC, Gallagher M, Giles WH. Phosphodiesterase 4D polymorphisms and the risk of cerebral infraction in a biracial population: the stroke prevention in young women study. Hum Mol Genet 2006; 15: 2468-2478.
18. Staton JM, Sayer MS, Hankey GJ, Attia J, Thakkinstian A, Yi Q, et al. Association between phosphodiesterase 4D gene and ischemic stroke. J Neurol Neurosurg Psychiatry 2006; 77: 1067-1069.
19. Meschia JF, Brott TG, Brown RD, Crook R, Worrall BB, Kissela B, et al. Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. Ann Neurol 2005; 58: 351-361.
20. Saleheen D, Bukhari S, Haider SR, Nazir A, Khanum S, Shafqat S, et al. Association of phosphodiesterase 4D gene with ischemic stroke in a Pakistani population. Stroke 2005; 36: 2275-2277.
21. Lohmussaar E, Gschwendtner A, Mueller JC, Org T, Wichmann E, Hamann G, et al. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 2005; 36: 731-736.
22. Kuhlenbaumer G, Berger K, Huge A, Lange E, Kessler C, John U, et al. Evaluation of single nucleotide polymorphisms in the phosphodiesterase 4D gene (PDE4D) and their association with ischemic stroke in a large German cohort. J Neurol Neurosurg Psychiatry 2006; 77: 521-524.
23. Liao YC, Lin HF, Guo YC, Yu ML, Liu CK, Juo SH. Sex-differential genetic effect of phosphodiesterase 4D (PDE4D) on carotid atherosclerosis. BMC Med Gene 2010; 11: 1471-2350.
24. Mitchell GF, Guo CY, Kathiresan S, Vasan RS, Larson MG, Vita JA, et al. Vascular stiffness and genetic variation at the endothelial nitric oxide synthase locus: the Framingham heart study. Hypertention 2007; 49: 1285-1290.
25. Doring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 2008; 40: 430-436.
26. Akey J, Jin L, Xiong M. Haplotypes vs single marker linkage disequilibrium tests: what do we gain? Eur J Hum Genet 2001; 9: 291-300.